NCT Number: NCT05733351
Phase: PHASE1
Trial Summary: This phase I trial tests the safety and effectiveness of vudalimab (XmAb20717) in combination with standard of care treatment abiraterone, enzalutamide, or abiraterone plus docetaxel in treating patie – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): Emory University
Acronym:
Vudalimab (XmAb20717) in Combination With Standard of Care Treatment in Patients With Metastatic Castration Sensitive Prostate Cancer
— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives